Editing Chloramphenicol (section)

==Veterinary uses==
Although its use in veterinary medicine is highly restricted, chloramphenicol still has some important veterinary uses.<ref>{{cite web | date = March 2012 | vauthors = Boothe DM |title= Chloramphenicol and Congeners |url= http://www.merckmanuals.com/vet/pharmacology/antibacterial_agents/chloramphenicol_and_congeners.html|publisher=Merck & Co., Inc. | location = Rahway, NJ, USA|access-date=31 October 2014|url-status=live|archive-url=https://web.archive.org/web/20141031232305/http://www.merckmanuals.com/vet/pharmacology/antibacterial_agents/chloramphenicol_and_congeners.html|archive-date=31 October 2014}}</ref> It is currently considered the most useful treatment of chlamydial disease in [[koala]]s.<ref>{{cite journal | vauthors = Govendir M, Hanger J, Loader JJ, Kimble B, Griffith JE, Black LA, Krockenberger MB, Higgins DP | title = Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis | journal = Journal of Veterinary Pharmacology and Therapeutics | volume = 35 | issue = 2 | pages = 147–154 | date = April 2012 | pmid = 21569052 | doi = 10.1111/j.1365-2885.2011.01307.x }}</ref><ref name=Griffith>{{cite journal | vauthors = Griffith JE, Higgins DP | title = Diagnosis, treatment and outcomes for koala chlamydiosis at a rehabilitation facility (1995-2005) | journal = Australian Veterinary Journal | volume = 90 | issue = 11 | pages = 457–463 | date = November 2012 | pmid = 23106328 | doi = 10.1111/j.1751-0813.2012.00963.x | doi-access = free }}</ref> The pharmacokinetics of chloramphenicol have been investigated in koalas.<ref>{{cite journal | vauthors = Black LA, McLachlan AJ, Griffith JE, Higgins DP, Gillett A, Krockenberger MB, Govendir M | title = Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus) | journal = Journal of Veterinary Pharmacology and Therapeutics | volume = 36 | issue = 5 | pages = 478–485 | date = October 2013 | pmid = 23157306 | doi = 10.1111/jvp.12024 }}</ref>